Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interfascial Injection of 10% Dextrose and 1% Lidocaine for Myofascial Pain Syndrome
TCTR20210202001Phase 2Not yet recruiting
- Sponsor
- N/A
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextrose, lidocaine in chronic myofascial pain (CMP), sponsored by N/A. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
dextroselidocaine
03
Conditions
chronic myofascial pain (CMP)
Beyond the preview
Go deeper on TCTR20210202001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210202001.